Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Docosahexaenoic Acid Inhibits Superoxide Dismutase 1 Gene Transcription in Human Cancer Cells: The Involvement of Peroxisome Proliferator-Activated Receptor α and Hypoxia-Inducible Factor-2α Signaling

Erin R. Tuller, Charles T. Beavers, Jessica R. Lou, Michael A. Ihnat, Doris M. Benbrook and Wei-Qun Ding
Molecular Pharmacology September 2009, 76 (3) 588-595; DOI: https://doi.org/10.1124/mol.109.057430
Erin R. Tuller
Departments of Obstetrics and Gynecology (E.R.T., D.M.B.), Biochemistry and Molecular Biology (D.M.B.), Pathology (C.T.B., J.R.L., W.-Q.D.), and Cell Biology (M.A.I.), University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles T. Beavers
Departments of Obstetrics and Gynecology (E.R.T., D.M.B.), Biochemistry and Molecular Biology (D.M.B.), Pathology (C.T.B., J.R.L., W.-Q.D.), and Cell Biology (M.A.I.), University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica R. Lou
Departments of Obstetrics and Gynecology (E.R.T., D.M.B.), Biochemistry and Molecular Biology (D.M.B.), Pathology (C.T.B., J.R.L., W.-Q.D.), and Cell Biology (M.A.I.), University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael A. Ihnat
Departments of Obstetrics and Gynecology (E.R.T., D.M.B.), Biochemistry and Molecular Biology (D.M.B.), Pathology (C.T.B., J.R.L., W.-Q.D.), and Cell Biology (M.A.I.), University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Doris M. Benbrook
Departments of Obstetrics and Gynecology (E.R.T., D.M.B.), Biochemistry and Molecular Biology (D.M.B.), Pathology (C.T.B., J.R.L., W.-Q.D.), and Cell Biology (M.A.I.), University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wei-Qun Ding
Departments of Obstetrics and Gynecology (E.R.T., D.M.B.), Biochemistry and Molecular Biology (D.M.B.), Pathology (C.T.B., J.R.L., W.-Q.D.), and Cell Biology (M.A.I.), University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Docosahexaenoic acid (DHA; n-3, 22:6) is known to have anticancer activity, but its mechanisms of action remain to be further elucidated. We recently demonstrated that DHA down-regulates superoxide dismutase (SOD) 1 gene expression, thereby weakening cellular antioxidant forces and enhancing cytotoxicity in various human cancer cells. The objective of this study was to investigate the mechanism of the inhibitory effect of DHA on SOD-1 gene expression in human cancer cells. A reporter gene assay indicated that DHA suppresses SOD-1 gene transcription in a time- and concentration-dependent manner in human cancer cells. Pretreatment with vitamin E did not block the inhibitory effect of DHA, indicating that this suppression does not depend on lipid peroxidation. The suppressive effect of DHA on SOD-1 gene transcription could be mimicked by the peroxisome proliferator-activator receptor (PPAR) α ligand clofibrate but not the PPARγ ligand troglitazone, suggesting the involvement of PPARα signaling. Deletion analysis of the key DNA binding elements in the SOD-1 gene promoter identified the distal hypoxia response element (HRE), but not the peroxisome proliferator response element or nuclear factor-κB element, as essential for the suppressive effects of DHA. Coimmunoprecipitation confirmed that PPARα, but not PPARγ, forms a complex with hypoxia-inducible factor (HIF)-2α in cancer cells. Chromatin immunoprecipitation analysis indicated that both DHA and clofibrate reduce HIF-2α binding to the HRE. Thus, we have identified the distal HRE in the SOD-1 gene promoter that mediates the suppression on the transcription of this gene by DHA, and we have demonstrated the involvement of PPARα and HIF-2α signaling in this event.

Footnotes

    • Received May 1, 2009.
    • Accepted June 15, 2009.
  • This study was supported by the Oklahoma Center for the Advancement of Science and Technology [Grant HR04-021]; the American Cancer Society [Grant IRG-05-066-01]; and the College of Medicine, University of Oklahoma Health Sciences Center [Grant COM 22134].

  • ABBREVIATIONS: DHA, docosahexaenoic acid; SOD, superoxide dismutase; PPRE, peroxisome proliferation-responsive element; PPAR, peroxisome proliferator-activated receptor; HIF, hypoxia-inducible factor; NF-κB, nuclear factor-κB; HRE, hypoxia-response element; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; 4-HNE, 4-hydroxy nonenal; LPS, lipopolysaccharide; PAGE, polyacrylamide gel electrophoresis; IP, immunoprecipitation; ChIP, coimmunoprecipitation; bp, base pair(s); ANOVA, analysis of variance; PUFA, polyunsaturated fatty acid; Lu, luciferase; EPA, eicosapentaenoic acid.

  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 76 (3)
Molecular Pharmacology
Vol. 76, Issue 3
1 Sep 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Docosahexaenoic Acid Inhibits Superoxide Dismutase 1 Gene Transcription in Human Cancer Cells: The Involvement of Peroxisome Proliferator-Activated Receptor α and Hypoxia-Inducible Factor-2α Signaling
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Docosahexaenoic Acid Inhibits Superoxide Dismutase 1 Gene Transcription in Human Cancer Cells: The Involvement of Peroxisome Proliferator-Activated Receptor α and Hypoxia-Inducible Factor-2α Signaling

Erin R. Tuller, Charles T. Beavers, Jessica R. Lou, Michael A. Ihnat, Doris M. Benbrook and Wei-Qun Ding
Molecular Pharmacology September 1, 2009, 76 (3) 588-595; DOI: https://doi.org/10.1124/mol.109.057430

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Docosahexaenoic Acid Inhibits Superoxide Dismutase 1 Gene Transcription in Human Cancer Cells: The Involvement of Peroxisome Proliferator-Activated Receptor α and Hypoxia-Inducible Factor-2α Signaling

Erin R. Tuller, Charles T. Beavers, Jessica R. Lou, Michael A. Ihnat, Doris M. Benbrook and Wei-Qun Ding
Molecular Pharmacology September 1, 2009, 76 (3) 588-595; DOI: https://doi.org/10.1124/mol.109.057430
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Hexahydroquinoline derivatives activate ADGRG1/GPR56
  • Action of Org 34167 on HCN channels
  • The effects of echinocystic acid on Kv7 channels
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics